Inhibition of Drp1 through therapeutic treatment with mdivi-1, a specific Drp1 inhibitor, resulted in significant decrease in murine tumor growth, providing additional support the importance of mitochondrial fission in cancer survival and proliferation [30]. This evidence concerns the gene DNM1L and cancer.